title: High sensitive C-reactive protein and interleukin 6 are not related to neointimal hyperplasia in paclitaxel eluting stents or bare metal stents. An intravascular ultrasound study.
abstract: Implantation of coronary stents after percutaneous coronary intervention (PCI) may result in an inflammatory response with an increase in high sensitive C-reactive protein (Hs-CRP) and interleukin 6 (IL-6). In 25 patients Hs-CRP and IL-6 increased after coronary artery stenting, however, the increase in the inflammatory response did not differ between PES and BMS stents. The inflammatory response did not predict neointima hyperplasia measured by intravascular ultrasound after 6 months.
authors.forename: Jakob
authors.initials: J
authors.lastname: Klitkou
authors.forename: Lisette Okkels
authors.initials: LO
authors.lastname: Jensen
authors.forename: Henrik Steen
authors.initials: HS
authors.lastname: Hansen
authors.forename: Per
authors.initials: P
authors.lastname: Thayssen
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D016503:Drug Delivery Systems; D006801:Humans; D006965:Hyperplasia; D015850:Interleukin-6 / Q000097:blood*; D017239:Paclitaxel / Q000008:administration & dosage*; D015607:Stents; D017539:Tunica Intima / Q000000981:diagnostic imaging / Q000276:immunology / Q000473:pathology; D018084:Ultrasonography, Interventional
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D015415:Biomarkers; D015850:Interleukin-6; D002097:C-Reactive Protein; D017239:Paclitaxel